计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| H610884-5mg |
5mg |
现货 ![]() |
| |
| H610884-25mg |
25mg |
现货 ![]() |
| |
| H610884-100mg |
100mg |
现货 ![]() |
|
| 别名 | 双肼酞嗪杂质 | 1-肼基酞嗪 |
|---|---|
| 英文别名 | 1-Phthalazinylhydrazine | Apresolin; Apresoline; Apressin | Hydralazine; phthalazin-1-ylhydrazine' | Hidral (TN) | NCGC00015501-03 | SPBio_000977 | CAS-304-20-1 | Hydralazine polistirex | Hydrazinophthalazine | Hidralazin | Hypophthalin | BDBM81461 | Hydr |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Hydralazine |
| 生化机理 | Hydralazine 具有抗氧化活性,抑制活性氧 (ROS) 释放和 O2·- 生成,IC50 分别为 9.53 mM 和 1.19 mM。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 1-hydrazinylidene-1,2-dihydrophthalazine |
| INCHI | 1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12) |
| InChi Key | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
| Smiles | NN=c1[nH]ncc2c1cccc2 |
| Isomeric SMILES | C1=CC=C2C(=C1)C=NN=C2NN |
| PubChem CID | 3637 |
| 分子量 | 160.18 |
| 分子量 | 160.180 g/mol |
|---|---|
| XLogP3 | 0.700 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 1 |
| 精确质量Exact Mass | 160.075 Da |
| 单同位素质量Monoisotopic Mass | 160.075 Da |
| 拓扑极表面积Topological Polar Surface Area | 63.800 Ų |
| 重原子数Heavy Atom Count | 12 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 150.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Guanxing Chen, Haohuai He, Lu Zhao, Qiujie Lv, Calvin Yu-Chian Chen. (2024) GINCM-DTA: A graph isomorphic network with protein contact map representation for potential use against COVID-19 and Omicron subvariants BQ.1, BQ.1.1, XBB.1.5, XBB.1.16. EXPERT SYSTEMS WITH APPLICATIONS, 236 (121274). [10.1016/j.eswa.2023.121274] |
| 2. Jinhua Li, Namrta Choudhry, Gang Lv, Naganna Nimishetti, Mallu Chenna Reddy, Hong Liu, Thaddeus D. Allen, Jing Zhang, Dun Yang. (2023) In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 232 (115415). [PMID:37120975] [10.1016/j.jpba.2023.115415] |
| 3. Liu Xinning, Liu Yuanchang, Zhao Guangjian, Zhang Yidan, Liu Lu, Wang Juan, Wang Yifan, Zhang Siyu, Li Xin, Guo Dongliang, Wang Peng, Xu Ximing. (2021) Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus. Frontiers in Microbiology, 11 [PMID:33537010] [10.3389/fmicb.2020.595083] |
| 4. Zhengsheng Mao, Youjia Yu, Gen Ba, Hongmei Zhao, Qifang Shi, Yue Cao, Weiran Xie, Jinsong Zhang, Hao Sun, Feng Chen. (2024) Non-cytochrome P450 enzyme aldehyde oxidase is involved in the oxidative metabolic pathway of diquat and its detoxification effect. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 199 (105805). [PMID:38458670] [10.1016/j.pestbp.2024.105805] |